Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Duke Clinical Research Institute, Durham, North Carolina; Division of Cardiology, Duke University School of Medicine, Durham, NC.
J Card Fail. 2022 Jun;28(6):916-923. doi: 10.1016/j.cardfail.2021.11.025. Epub 2022 Jan 3.
Worsening heart failure (HF) often requires hospitalization but in some cases may be managed in the outpatient or emergency department (ED) settings. The predictors and clinical significance of ED visits without admission vs hospitalization are unclear.
The ASCEND-HF trial included 2661 US patients hospitalized for HF with reduced or preserved ejection fraction. Clinical characteristics were compared between patients with a subsequent all-cause ED visit (with ED discharge) within 30 days vs all-cause readmission within 30 days. Factors associated with each type of care were assessed in multivariable models. Multivariable models landmarked at 30 days evaluated associations between each type of care and subsequent 150-day mortality.
Through 30-day follow-up, 193 patients (7%) had ED discharge, 459 (17%) had readmission, and 2009 (76%) had neither urgent visit. Patients with ED discharge vs readmission were similar with respect to age, sex, systolic blood pressure, ejection fraction, and coronary artery disease, whereas ED discharge patients had a modestly lower creatinine (P < .01). Among patients with either event within 30 days, a higher creatinine and prior HF hospitalization were associated with a higher likelihood of readmission, as compared with ED discharge (P < .02). Landmarked at 30 days, rates of death during the subsequent 150 days were 21.0% for patients who were readmitted and 11.4% for patients discharged from the ED. Compared with patients who were readmitted, ED discharge was independently associated with lower 150-day mortality (adjusted hazard ratio 0.58, 95% confidence interval 0.36-0.92, P = .02).
In this cohort of US patients hospitalized for HF, worse renal function and prior HF hospitalization were associated with a higher likelihood of early postdischarge readmission, as compared with ED discharge. Although subsequent mortality was high after discharge from the ED, this risk of mortality was significantly lower than patients who were readmitted to the hospital.
心力衰竭(HF)恶化通常需要住院治疗,但在某些情况下,也可以在门诊或急诊部(ED)进行管理。ED 就诊但未住院与住院的预测因素和临床意义尚不清楚。
ASCEND-HF 试验纳入了 2661 名因射血分数降低或保留的 HF 住院的美国患者。比较了在 30 天内因任何原因再次 ED 就诊(ED 出院)与 30 天内因任何原因再次入院的患者之间的临床特征。多变量模型评估了每种治疗方式相关的因素。以 30 天为时间节点的多变量模型评估了每种治疗方式与随后 150 天死亡率之间的关系。
在 30 天的随访中,193 名患者(7%)接受了 ED 出院治疗,459 名患者(17%)接受了再入院治疗,2009 名患者(76%)既没有紧急就诊也没有再入院。与再入院患者相比,ED 出院患者的年龄、性别、收缩压、射血分数和冠状动脉疾病相似,而 ED 出院患者的肌酐水平略低(P <.01)。在 30 天内发生任何一种情况的患者中,肌酐升高和既往 HF 住院史与再入院的可能性更高相关,而与 ED 出院相比(P <.02)。以 30 天为时间节点,在随后的 150 天内,再入院患者的死亡率为 21.0%,ED 出院患者的死亡率为 11.4%。与再入院患者相比,ED 出院与较低的 150 天死亡率独立相关(调整后的危险比为 0.58,95%置信区间为 0.36-0.92,P = .02)。
在本项纳入美国 HF 住院患者的队列研究中,与 ED 出院相比,肾功能更差和既往 HF 住院史与出院后早期再入院的可能性更高相关。尽管 ED 出院后的死亡率较高,但与再入院患者相比,这种死亡率的风险显著降低。